Representative before the EPO

Employment test 11 - 50 employees
Company dna cabinet becker and associes
operating since 1999
Headquarter in Paris
active in Legal Services and IP Consulting

We have observed 22 EP applications Anne-Caroline Starck-Loudes has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11815529

DERMATOLOGICAL FOAMS OBTAINED FROM A GEL OR SUSPENSION CONTAINING BENZOYL PEROXIDE

IPC classification:
A61K 9/06, A61K 9/10, A61K 9/12, A61K 31/327, A61P 17/10
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION REQUESTED
EP11815526

DERMATOLOGICAL FOAMS OBTAINED FROM A GEL OR SUSPENSION CONTAINING A COMBINATION OF ADAPALENE AND BENZOYL PEROXIDE

IPC classification:
A61K 9/06, A61K 9/10, A61K 9/12, A61K 31/192, A61K 31/327
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP11815527

DERMATOLOGICAL FOAMS OBTAINED FROM A GEL OR SUSPENSION CONTAINING ADAPALENE

IPC classification:
A61K 9/06, A61K 9/10, A61K 9/12, A61K 31/192, A61P 17/10
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP12306143

Methods and kits for predicting the sensitivity of a subject to chemotherapy

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Institut Gustave Roussy
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION WITHDRAWN
EP12729152

NEW TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP12729153

NEW TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP12732819

NEW TH-17 DIFFERENTIATION MARKERS FOR ROSACEA AND USES THEREOF

IPC classification:
C12Q 1/68
Applicant:
University of Münster (Westfälische Wilhelms-Universität Münster)
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP12755992

METHODS FOR AGGREGATION AND DIFFERENTIATION OF MAGNETIZED STEM CELLS

IPC classification:
C12N 5/0735, C12N 5/077, C12N 5/0775
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Cabinet Regimbeau
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP12761744

A HUMAN EPITHELIAL CELL LINE FOR 3D -MODELIZING OF CANCER AND TREATMENT THEREOF

IPC classification:
C07K 14/025, C12N 5/071, G01N 33/50
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP12761743

HUMAN KERATINOCYTES PTCH1 CELL LINE

IPC classification:
C07K 14/025, C12N 15/867, C12Q 1/68
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP12766635

FIBROBLASTS CELLULAR MODEL FOR ASSESSING EFFICACY OF CANCER TREATMENTS BY SHH/PTCH PATHWAY ANTAGONISTS

IPC classification:
C07K 14/005, C07K 14/025, C07K 14/15, C12N 5/077, C12N 5/10, C12N 15/867
Applicant:
Galderma Research & Development
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION IN PROGRESS
EP13305198

Inhibitors of Na(v) 1.9 channel activity and uses thereof for treating pain

IPC classification:
A61K 31/575, A61P 29/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12797734

HUMAN MAST CELL LINES, PREPARATION AND USES

IPC classification:
C12N 5/0787, G01N 33/50
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Vienna University of Medicine (Medizinische Universität Wien)
Applicant:
École normale supérieure de Cachan
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP12806026

NANOPARTICLES COMPRISING METALLIC AND HAFNIUM OXIDE MATERIALS, PREPARATION AND USES THEREOF

IPC classification:
A61K 9/51, A61K 33/24, A61P 35/00
Applicant:
Nanobiotix
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP14165240

Compounds and uses thereof to induce an immunogenic cancer cell death in a subject

IPC classification:
A61K 31/7048, C12Q 1/68
Applicant:
Institut Gustave Roussy
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
PATENT GRANTED
EP13702062

PROTEIN CHIPS, PREPARATION AND USE THEREOF

IPC classification:
G01N 33/543, G01N 33/564, G01N 33/68
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Les Hospices Civils de Lyon
Applicant:
Université Claude Bernard Lyon I (UCBL)
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
GRANT OF PATENT INTENDED
EP13306780

AP5B1 as a new marker for moderate to severe acne

IPC classification:
C12Q 1/68
Applicant:
Galderma Research & Development
Applicant:
King's College London
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306779

OVOL1 as a new marker for moderate to severe acne

IPC classification:
C12Q 1/68
Applicant:
Galderma Research & Development
Applicant:
King's College London
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13306799

Pharmaceutical composition comprising nanoparticles, preparation and uses thereof

IPC classification:
A61K 41/00, A61K 47/48
Applicant:
Nanobiotix
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12701014

TRANSGENIC PIG FOR MUTANT GUCY2D AS CONE DYSTROPHY MODEL

IPC classification:
A01K 67/027, C12N 9/88, C12N 15/85
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
The University Court of The University of Aberdeen
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14726894

ANTI-REGURGITATION COMPOSITION MAINTAINING GUT MOTILITY

IPC classification:
A61P 1/04, A23L 33/00, A23L 29/231, A23L 29/238
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
EXAMINATION REQUESTED
EP11794796

ANTI-REGURGITATION AND/OR ANTI-GASTROOESOPHAGEAL REFLUX COMPOSITION, PREPARATION AND USES

IPC classification:
A23L 1/0524, A23L 1/054, A23L 1/29, A61P 1/04
Agent:
Anne-Caroline Starck-Loudes, Cabinet Becker & Associés
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature